Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Resource
  • Published:

Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways

An Author Correction to this article was published on 11 October 2019

This article has been updated


The molecular and cellular processes that lead to renal damage and to the heterogeneity of lupus nephritis (LN) are not well understood. We applied single-cell RNA sequencing (scRNA-seq) to renal biopsies from patients with LN and evaluated skin biopsies as a potential source of diagnostic and prognostic markers of renal disease. Type I interferon (IFN)-response signatures in tubular cells and keratinocytes distinguished patients with LN from healthy control subjects. Moreover, a high IFN-response signature and fibrotic signature in tubular cells were each associated with failure to respond to treatment. Analysis of tubular cells from patients with proliferative, membranous and mixed LN indicated pathways relevant to inflammation and fibrosis, which offer insight into their histologic differences. In summary, we applied scRNA-seq to LN to deconstruct its heterogeneity and identify novel targets for personalized approaches to therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Cell lineage determination by dimensionality reduction analysis.
Fig. 2: Subclustering of keratinocytes reveals two rare skin-specific cell types.
Fig. 3: Subclustering of tubular cells identifies major tubular cell subtypes of the nephron.
Fig. 4: IFN-response signature differentiates patients with LN from healthy control subjects and response to treatment.
Fig. 5: A fibrotic gene signature as a potential prognostic marker for patients non-responsive to treatment.
Fig. 6: Putative receptor–ligand interactions between kidney and skin cells.
Fig. 7: Differential expression and pathway enrichment analysis of tubular cells and keratinocytes between membranous and proliferative LN.
Fig. 8: Differential expression and pathway enrichment analysis of tubular cells between membranous or proliferative LN and mixed class disease.

Similar content being viewed by others

Data availability

Raw and processed data will be available from dbGAP with accession number phs001457.v1.p1. Quality-controlled data and data matrices can be obtained from Immport with study number SDY997 and experiment number EXP15077.

Code availability

All software packages and programs are publicly available and open source. Scripts used to analyze the data with these packages are available from There is no restriction on the use of the code or data.

Change history

  • 11 October 2019

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  1. Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110–2121 (2011).

    Article  CAS  Google Scholar 

  2. Mohan, C. & Putterman, C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat. Rev. Nephrol. 11, 329–341 (2015).

    Article  CAS  Google Scholar 

  3. Weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15, 241–250 (2004).

    Article  Google Scholar 

  4. Yu, F. et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 international society of nephrology and renal pathology society system. Kidney Int. 77, 820–829 (2010).

    Article  Google Scholar 

  5. Hsieh, C. et al. Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring. Arthritis Care Res. 63, 865–874 (2011).

    Article  Google Scholar 

  6. Alsuwaida, A. O. Interstitial inflammation and long-term renal outcomes in lupus nephritis. Lupus 22, 1446–1454 (2013).

    Article  CAS  Google Scholar 

  7. Misra, R. & Gupta, R. Biomarkers in lupus nephritis. Int. J. Rheum. Dis. 18, 219–232 (2015).

    Article  Google Scholar 

  8. Reich, A., Marcinow, K. & Bialynicki-Birula, R. The lupus band test in systemic lupus erythematosus patients. Ther. Clin. Risk Manag. 7, 27–32 (2011).

    Article  Google Scholar 

  9. Der, E. et al. Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis. JCI Insight 2(9), e93009 (2017).

  10. Ofengeim, D., Giagtzoglou, N., Huh, D., Zou, C. & Yuan, J. Single-cell RNA sequencing: unraveling the brain one cell at a time. Trends Mol. Med. 23, 563–576 (2017).

    Article  CAS  Google Scholar 

  11. Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).

    Article  CAS  Google Scholar 

  12. Kim, K.-T. et al. Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma. Genome Biol. 17, 80 (2016).

    Article  Google Scholar 

  13. Young, M. D. et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science 361, 594–599 (2018).

    Article  CAS  Google Scholar 

  14. Park, J. et al. Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease. Science 360, eaar2131 (2018).

  15. Schittek, B. et al. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2, 1133–1137 (2001).

    Article  CAS  Google Scholar 

  16. Du, J. et al. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by mitf in melanocytes and melanoma. Am. J. Pathol. 163, 333–343 (2003).

    Article  CAS  Google Scholar 

  17. Elkon, K. B. & Stone, V. V. Type I interferon and systemic lupus erythematosus. J. Interferon Cytokine Res. 31, 803–812 (2011).

    Article  CAS  Google Scholar 

  18. Lan, H. Y. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr. Opin. Nephrol. Hypertens. 12, 25–29 (2003).

    Article  CAS  Google Scholar 

  19. Ng, Y. Y. et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 54, 864–876 (1998).

    Article  CAS  Google Scholar 

  20. Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial–mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196 (2014).

    Article  CAS  Google Scholar 

  21. Wolf, G. & Ziyadeh, F. N. Renal tubular hypertrophy induced by angiotensin II. Semin. Nephrol. 17, 448–454 (1997).

    CAS  PubMed  Google Scholar 

  22. Zhang, X. et al. TIMP-1 promotes age-related renal fibrosis through upregulating ICAM-1 in human TIMP-1 transgenic mice. J. Gerontol. A Biol. Sci. Med. Sci. 61, 1130–1143 (2006).

    Article  Google Scholar 

  23. Ling, X. B. et al. Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J. Am. Soc. Nephrol. 21, 646–653 (2010).

    Article  CAS  Google Scholar 

  24. Su, Z. et al. Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease. J. Intern. Med. 276, 470–485 (2014).

    Article  CAS  Google Scholar 

  25. Parikh, S. V. et al. Molecular imaging of the kidney in lupus nephritis to characterize response to treatment. Transl. Res. 182, 1–13 (2017).

    Article  CAS  Google Scholar 

  26. Strutz, F. et al. Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Kidney Int. 57, 1521–1538 (2000).

    Article  CAS  Google Scholar 

  27. Smith, E. R., Tan, S.-J., Holt, S. G. & Hewitson, T. D. FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts. Sci. Rep. 7, 3345 (2017).

    Article  Google Scholar 

  28. Meran, S. & Steadman, R. Fibroblasts and myofibroblasts in renal fibrosis. Int. J. Exp. Pathol. 92, 158–167 (2011).

    Article  CAS  Google Scholar 

  29. Yang, J. & Liu, Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159, 1465–1475 (2001).

    Article  CAS  Google Scholar 

  30. Yang, J. & Liu, Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13, 96–107 (2002).

    CAS  PubMed  Google Scholar 

  31. Castellano, G. et al. Local synthesis of interferon-alpha in lupus nephritis is associated with type I interferons signature and LMP7 induction in renal tubular epithelial cells. Arthritis Res. Ther. 17, 72 (2015).

    Article  Google Scholar 

  32. Stephenson, W. et al. Single-cell RNA-seq of rheumatoid arthritis synovial tissue using low-cost microfluidic instrumentation. Nat. Commun. 9, 791 (2018).

    Article  Google Scholar 

  33. MacParland, S. A. et al. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat. Commun. 9, 4383 (2018).

    Article  Google Scholar 

  34. Vento-Tormo, R. et al. Single-cell reconstruction of the early maternal–fetal interface in humans. Nature 563, 347 (2018).

    Article  CAS  Google Scholar 

  35. Austin, H. A., Boumpas, D. T., Vaughan, E. M. & Balow, J. E. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 45, 544–550 (1994).

    Article  Google Scholar 

  36. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10–12 (2011).

    Article  Google Scholar 

  37. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).

    Google Scholar 

  38. Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).

    Article  CAS  Google Scholar 

  39. Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015).

    Article  CAS  Google Scholar 

  40. Pavličev, M. et al. Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal–fetal interface. Genome Res. 27, 349–361 (2017).

    Article  Google Scholar 

  41. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).

    Article  Google Scholar 

  42. Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90–W97 (2016).

    Article  CAS  Google Scholar 

  43. Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).

    Article  Google Scholar 

  44. Croft, D. et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 42, D472–D477 (2014).

    Article  CAS  Google Scholar 

  45. Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 46, D649–D655 (2018).

    Article  CAS  Google Scholar 

  46. Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30 (2000).

    Article  CAS  Google Scholar 

  47. Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353–D361 (2017).

    Article  CAS  Google Scholar 

  48. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457–D462 (2016).

    Article  CAS  Google Scholar 

Download references


The authors thank A. Hurley and the Research Facilitation Office staff at Rockefeller University for regulatory and administrative assistance who are supported in part by grant no. UL1TR001866 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program. This work was supported by the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network. AMP is a public–private partnership (AbbVie, Arthritis Foundation, Bristol-Myers Squibb, Foundation for the National Institutes of Health, Lupus Foundation of America, Lupus Research Alliance, Merck Sharp & Dohme, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Pfizer, Rheumatology Research Foundation, Sanofi and Takeda Pharmaceuticals) created to develop new ways of identifying and validating promising biological targets for diagnostics and drug development. Funding was provided through grants from the National Institutes of Health (grant nos. UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694 and UM2-AR067678). We thank the Rockefeller University Genomics Resource Center for providing access to the Fluidigm C1 system and Illumina sequencing.

Author information

Authors and Affiliations




J.B., T.T. and C.P. conceived the study with help from S. Ranabothu, J.J., J. Guthridge and S. Raychaudhuri. Input regarding the skin came from R.C. and H.M.B. E.D., H.S. and S. Ranabothu performed all biopsy dissociations and single-cell experiments. B.G., P.I., H.M.B., M. Koenigsberg, M.M., N.J., N.B. and E.S. assisted with patient consent and sample acquisition of LN biopsies. H.R., J.R. and J. Graham assisted with patient consent and sample acquisition of live kidney donor tissue. Renal biopsy histology was evaluated by M.W. and J.P. H.M.B. and P.I. performed all skin biopsies. Analysis was performed by E.D., H.S., P.M., K.S. and M. Kustagi. E.D., J.B., T.T. and C.P. prepared and wrote the manuscript.

Corresponding authors

Correspondence to Jill Buyon, Thomas Tuschl or Chaim Putterman.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Integrated supplementary information

Supplementary Figure 1 The tSNE plot with cells colored by patient and tissue of origin.

Points each represent a single cell and are colored to reflect the tissue and patient as labeled. The relative position of each cell (n = 4,019 cells from n =17 skin and n = 21 kidney samples) is based on the analysis which was performed in Fig. 1b.

Supplementary Figure 2 Correlation between cell percentages as determined by histological identification or scRNA-seq.

The cell-type percentages of the major cell types identified (tubular cells, endothelial cells, leukocytes, fibroblasts, mesangial cells, n = 5 cell types) were determined by histological morphology (Y-axis) or scRNA-seq (X-axis) for biopsies (n = 2) and were correlated using Pearson’s correlation. Points represent log2 transformed percentages of cell types with open circles and filled circles representing the two distinct biopsies.

Supplementary Figure 3 Correlation between averaged single-cell and bulk RNA-seq expression.

a, Pearson’s correlation between averaged renal single cells (n = 1 averaged profile) and a bulk sequenced renal biopsy (n = 1 biopsy) for each gene (n = 21,868 gene entries). b, Pearson’s correlation between averaged skin single cells (n = 1 averaged profile) and bulk sequenced skin cells (n = 1 biopsy) for each gene (n = 21,868 gene entries). c, Pearson’s correlation between averaged renal single cells (n = 1 averaged profile) and bulk sequenced skin cells (n = 1 biopsy) for each gene (n = 21,868 gene entries). d, Pearson’s correlation between averaged skin single cells (n = 1 average profile) and a bulk sequenced renal biopsy (n = 1 biopsy) for each gene (n = 21,868 gene entries).

Supplementary Figure 4 Receiver operating characteristic analysis of two logistic regression models predicting response to treatment created by Parikh et al.

a, The 3-gene model shows an AUC of 0.8 when applied to our cohort (n = 18). b,The 5-gene model shows an AUC of 0.81 when applied to our cohort (n = 18).

Supplementary information

Supplementary Information

Supplementary Figures 1–4

Reporting Summary

Supplementary Table 1

Patient demographics, medications, clinical data and sequencing details

Supplementary Table 2

Top 30 most differentially expressed genes between cell type clusters. Differentially expressed genes between each cluster for keratinocytes (n = 1,939), tubular cells (n = 1,221), mesangial cells (n = 63), fibroblasts (n = 95), endothelial cells (n = 130) and leukocytes (n = 120) using Seurat’s differential analysis

Supplementary Table 3

Percentage contribution of each patient to each cell type. Each column is a cell type and each row represents an individual sample’s (n = 44 tissue samples) contribution to that cell type

Supplementary Table 4

Significantly upregulated genes in clinical groups for both tubular cells and keratinocytes. Sheet 1 is upregulated genes in non-responders (n = 13) versus responders (n = 5). Sheet 2 is upregulated genes in responders (n = 5) versus non-responders (n = 13). Sheet 3 is genes upregulated in proliferative (n = 8) versus membranous (n = 6). Sheet 4 is upregulated in membranous (n = 6) versus proliferative (n = 8)

Supplementary Table 5

Genes used for IFN-response cumulative distribution function. Column A contains ubiquitously expressed genes (n = 264) and Column B contatins IFN-responsive genes (n = 212)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Der, E., Suryawanshi, H., Morozov, P. et al. Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol 20, 915–927 (2019).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research